Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Caitlin E. Cox

November 18, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Todd Neale

October 01, 2024

News Conference News ESC 2024

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

L.A. McKeown

September 10, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Michael O'Riordan

May 01, 2023

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

L.A. McKeown

October 28, 2022

Advertisement

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

April 2025 Dispatch for the CV Team

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Who Benefits Most From Semaglutide and How Long Will That Take?

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content